Skip to content
iasusa cover art

All episodes

iasusa, 500 episodes. Page 3 of 5.

#
Title
201

Pathogenesis of Long COVID: Organicity and Mechanisms

202

Long COVID Diagnosis and Management: A Case-Based Panel Discussion

203

Long COVID and HIV

204

Long COVID Clinical Trials: Challenges and Opportunities

205

Closing

206

(June 15, 2023) A Conversation About Dispatches From the AIDS Pandemic: A Public Health Story

207

Welcome and Introduction

208

New and Investigational Antiretroviral Drugs and Formulations

209

In Case You Missed It: CROI 2023, Publications, and Guidelines

210

Challenging Cases in Antiretroviral Therapy and Panel Discussion

211

The Latest Updates on HIV Prevention

212

Treatment and Management of Syphilis and Gonorrhea

213

Managing Cardiovascular Disease in People with HIV

214

Primary Care for People with HIV: Immunizations

215

(February 2, 2023) Latest Issues in COVID-19: Vaccines, Long COVID, Prevention, and Pediatrics

216

(Apri 20,2023) Latest Update on Urgent Virus Outbreaks: April 2023

217

Welcome and Introductoin

218

Key Updates from CROI 2023

219

New and Investigational Antiretroviral Drugs and Formulations

220

Challenging Cases in Antiretroviral Therapy and Panel Discussion

221

Infant Feeding and People with HIV

222

Cardiovascular Disease and HIV

223

Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol

224

Preexposure Prophylaxis

225

Managing Sexually Transmitted Infection: Doxycycline Postexposure Prophylaxis

226

Closing Remarks

227

New and Investigational Antiretroviral Drugs and New Strategies for HIV Management

228

Antiretroviral Therapy Cases From the Clinic(ians)

229

Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol

230

Testing and Treating (and Preventing) Sexually Transmitted Infections in People With HIV

231

Latest Strategies in the Prevention of HIV

232

Long COVID: Diagnosis and Management

233

Closing

234

Welcome And Introduction

235

mRNA Vaccine Technology and the Prospects for an HIV Vaccine

236

Key Updated from CROI 2023

237

(March 21, 2023) Latest Update on Urgent Virus Outbreaks: March 2023

238

(January 9, 2023) Latest Update on Urgent Virus Outbreaks: COVID-19, RSV, and Influenza

239

Comorbidities In The Setting Of Antiretroviral Therapy

240

Recent Co-Infections In The Setting Of ART: MPX And COVID - 19

241

When And How To Switch

242

Substance Use Disorder

243

HIV Prevention And STI Screening And Prevention

244

Closing Remarks

245

Welcome And Introductions

246

When And What To Start

247

bNAbs: Where Are We Going?

248

In Case You Missed It: Updates From Recent Publications And Meetings

249

The Effect of the Pandemic on Ending the HIV Epidemic Initiative

250

Providing Gender Affirming Care

251

Closing Remarks

252

Welcome And Introductions

253

Antiretroviral Therapy Cases: HIV Prevention and Treatment

254

Anal Cancer Screening: What Now?

255

3.7.Closing

256

mRNA Vaccine Development for HIV Vaccines

257

New and Investigational Antiretroviral Drugs

258

Antiretroviral Therapy Cases From the Clinic(cians)

259

Providing Gender-Affirming Care

260

An Update on Hepatitis B Virus Infection

261

Management of AIDS-Related Opportunistic Infections

262

Methicillin-Resistant Straphylococcus aureus (MRSA) in PWH

263

Opioid Use Disorder

264

Urgent Emerging Infections in HIV: Monkeypox

265

Reducing Health Disparities Among Disparate Populations

266

Breast Feeding and Individuals With HIV

267

HIV Prevention From the Centers of Disease Control and Prevention Perspective

268

Current CDC STI Treatment Guidelines: An Update

269

HIV Practitioner Burnout Panel

270

(September 15, 2022) Continued Discussion on Urgent Virus Outbreaks: COVID-19, Monkeypox, and More

271

Aging And HIV

272

In Case You Missed It: The Latest in HIV Literature and Monkeypox

273

New And Investigational Drugs

274

Preexposure Prophylaxis

275

Recognizing And Managing Practitioner Burnout

276

Special Panel Session

277

Antiretroviral Therapy Cases From the Clinic(ians): A Case-Based Presentation and Panel Discussion

278

Welcome And Introductions

279

(August 23, 2022) Urgent Virus Outbreaks: COVID-19 and Monkeypox

280

Closing

281

Difficult Cases In Inpatient Care For COVID - 19

282

Difficult Cases In Prevention And Outpatient Care For COVID - 19

283

Post - COVID Complications

284

Roundtable Discussion

285

Welcome And Introductions

286

The Clinical Relationship Between HIV And COVID - 19

287

(July 7, 2022) COVID-19 Rebound, Subvariants BA.4 and BA.5, Vaccines, and More

288

Welcome And Introductions

289

The Revolution of MRNA Vaccines: Implications for an HIV Vaccine

290

CROI 2022 Review

291

New and Investigational Drugs for Treatment and Prevention

292

Challenges Cases in Antiretroviral Therapy and Panel Discussion

293

The Clinical Relationship Between HIV and COVID-19

294

Special Panel Session: 40 Years Later

295

(June 7, 2022) Detailed Discussion on COVID-19 Vaccines, Boosters, Therapeutics, Variants, and More

296

(May 6, 2022) COVID-19 Therapeutics, 2nd Booster, Variants of Variants, and COVID-19 in Children

297

Controversies In Managing Sexually Transmitted Infections: A Case-Based Panel Discussion

298

Frailty Screening Preventing And Intervening

299

Optimizing Preexposure Prophylaxis

300

Screening For Anal Cancer: When to Screen and What to Do With the Results